Tag: NERV

Tuesday’s Big Movers, 6 New Ideas

Tuesday’s Movers:

We cast a pretty wide net on Tuesday with respect to the offering of six potential options plays listed in our premarket report for the session. We got nearly all positive results, with only one single set of contracts on the entire board failing to post good gains during the day.

We had watchlisted the SIG Weekly $93-92 Puts, the UNFI Weekly $36-37 Calls, the BNS Weekly $67.50 Calls, the MDB Weekly $400-405 Calls, the BYND Weekly $1.50 Calls, and the CRDO Weekly $195-200 Calls. Here were the results off of all of those contracts:

SIG Weekly $93-92 Puts
$93: 2.23-5.00 (+124%)
$92: N/A
_____

UNFI Weekly $36-37 Calls
$36: 1.55-3.30 (+113%)
$37: 2.00-2.60 (+30%)
_____

BNS Weekly $67.50 Calls
$67.50: 2.20-3.30 (+100%)
_____

MDB Weekly $400-405 Calls
$400: 11.90-23.50 (+97%)
$402.50: 12.96-20.41 (+57%)
$405: 11.03-18.95 (+72%)
_____

BYND Weekly $1.50 Calls
$1.50: .05-.17 (+220%)
_____

CRDO Weekly $195-200 Calls
$195: 6.56-20.65 (+215%)
$197.50: 7.69-19.07 (+150%)
$200: 4.00-17.04 (+326%)

Fresh Options Ideas:
SPY 12/03 $683-684 Calls
GTLB Weekly $39 Puts
AEO Weekly $23-23.50 Calls
THO Weekly $110 Calls
MRVL Weekly $100 Calls
PSTG Week;y $85 Puts

Extended Watchlist:
VRAX, IXHL, PMAX, ARTL, HTOO, NERV, CMCT, SMX, BOOT

Monday Recap, 3 New Chances

Monday’s Movers

We kept the hot streak we ended last week with going strong with Monday’s premarket report. We were tracking a trio of potential plays, and were able to sustain our success and carrying it over to a new trading week. We led things off with some SPY calls, which were extremely strong as the markets posted a solid bullish session.

Our whole slate of tracked targets for Monday were the SPY 10/20 $666-667 Calls, the CLF Weekly $14.50-15 Calls, and the SMMT Weekly $19.50-19 Puts, and these were biggest intraday runs made my each of them for the session:

SPY 10/20 $666-667 Calls
$666: 2.46-6.21 (+152%)
$667: 1.81-5.22 (+188%)
_____

CLF Weekly $14.50-15 Calls
$14.50: 1.05-2.37 (+126%)
$15: .75-1.80 (+140%)
_____

SMMT Weekly $19.50-19 Puts
$19.50: .70-.90 (+29%)
$19: .65-.96 (+48%)

Fresh Options Ideas:
DHR Weekly $215-220 Calls
RTX Weekly $167.50-170 Calls
KO weekly $70 Calls

Extended Watchlist:
TNON, YDKG, EOSE, DCGO, IBIO, IFBD, PSTV, NERV, VSEE, GSIT, BYND,

Fresh Earnings and Form-4 Plays

Yesterday’s Clean Sweep:

We fared quite well yesterday morning with our first options targets of the week from our premarket report. We had presented four possibilities, and ended up seeing some pretty good intraday movement from each of them. The pickings are slim with regard to earnings reporters, but we had a relatively decent selection to work with.

We ended up tracking the WBA Weekly $30-29 Puts, the SNX 07/21 $90 Puts, the KFY 07/21 $50 Puts and the AXON 07/21 $190-195 Calls. They produced the following intraday runs, and total possible gains: 

WBA Weekly $30-29 Puts
$30: 1.08-1.89 (+75%)
$29.50: .81-1.29 (+59%)
$29: .40-1.02 (+155%)
_____

SNX 07/21 $90 Puts
$90: 2.14-5.00 (+134%)
_____

KFY 07/21 $50 Puts
$50: 1.10-3.92 (+256%)
_____

AXON 07/21 $190-195 Calls  
$190: 7.80-9.70 (+24%)
$195: 5.00-6.40 (+28%)

Fresh Options Ideas:
AVAV 07/21 $95-100 Calls
GIS 07/21 $75-72.50 Puts
MSGE 07/21 $35 Calls

Extended Watchlist:
TOVX, OPK, KLR, DOMA, IMBI, NERV, AVTX, GNPX, BAOS

Blue Horseshoe Stocks: More Bottom-Plays

Seres Therapeutics, Inc. MCRB 

It was a pretty slow start to the week yesterday with the markets gapping up early, but falling into decline throughout the session. That didn’t stop the one fresh idea we did have in our morning report from posting a respectable performance on the day.

We referred to MCRB as a ‘prime bottom play’ and while it didn’t exactly explode out of the gate, what we did see was certainly a step in the right direction. From a low of 2.63, the stock ran a modest but solid 16% to a high of 3.06. More importantly, it preserved its momentum by holding the three-dollar mark into the close. A good first day by any stretch of the imagination.

We’ll continue to monitor our longer term options idea that we included, the MCRB 07/19 $2.50 Calls which stand to do well in coming weeks if the stock can continue to maintain the current trend. Yesterday’s session was the fourth consecutive day that the stock has recorded higher lows, and we’ll want to see more of that moving forward.

Verastem Inc. VSTM 

Speaking of bottom plays, we’ve got another one to add to our radars this morning in VSTM. This stock has lost a ton of value over the past year, and recently began to show signs of a rebound. We like it for its technical setup and volatility potential. We will remain interested in tracking VSTM for as long as it can maintain support at 1.72 or better.

VSTM is considered by some to be a speculative buyout play as well. Just this week the company has reported positive early stage data on Copiktra, the company’s leukemia treatment under development. Definitely an interesting story to follow.

____

Celestica Inc. CLS

Perhaps even more attractive as a bottom play than the above mentioned stock, we’ve got CLS, which just began to show signs of life after recording a new annual low at the beginning of this month.

If the stock can manage to break its 50DMA at 7.09, there’s a real chance that it could produce significant gains, filling the gap to the topside on the chart. Interesting to naote about CLS as well, is that the company’s EPS has grown by nearly 90% over the past year. When taking that into consideration, its current valuation doesn’t make a whole lot of sense.

Extended Watchlist:
CBAY, DERM, SAVA, NERV, NDRA, PHUN, VIVE

Blue Horseshoe Stocks: CPXX Buyout & More

Celator Pharmaceuticals, Inc. CPXX

Just under a couple of weeks ago, we chose to alert CPXX in our morning report from May 19th. The stock had been gaining significant ground in sessions prior to that, to the point we felt it warranted our attention.

It was a good thing we drew attention to it when we did, because what followed was a solid run-up from our observed low of 15.73 into the $18-range. This morning, our witnessed gains received yet another big boost, as a takeover has been announced that will see CPXX acquired by Jazz Pharmaceuticals for $1.5B, or, 30.25 a share.

As of this morning’s premarket high on CPXX, our observed PPS increase on the stock in a matter of just seven trading sessions has been extended to a very solid 95%

Lending Club Corp. LC

Speaking of extended gains from plays that we’ve been discussing recently, we also had LC put up a noteworthy performance on Friday that culminated in new highs for us since we began tracking the stock.

Just to refresh our readers’ memories, we called LC as a bottom-bounce candidate last Monday, at which time we observed a low of 4.19. Friday’s run carried it to a high of 5.10, marking an intraweek move of 22%

We’re going to want to continue to monitor its progress as the chart is still looking quite ripe for a continued uptrend. As you can see on the provided chart snapshot, we’ve got a steadily-strengthening RSI combined with a recent bullish MACD cross in addition to a significant gap on the chart that runs from the 5.50’s to the 6.70’s.

Cliffs Natural Resources, Inc. CLF

We’re also going to place a tag on CLF this morning. We like the recent activity and the look of the current chart. Like the aforementioned play, we’re faced with a number of bullish indicators that are urging us to keep CLF on our radars as we kick off a new trading week.

Extended Watchlist:
CATS, NHMD, SQI, GEVO, NERV, FRO

Get Our FREE Daily Reports!

SUBSCRIBE